Dr. Gupta graduated from the P T B D S Postgrad Inst of Med Sci, M Dayanand Univ, Rohtak, Haryana, India in 1985. He works in Middletown, OH and specializes in Clinical Cardiac Electrophysiology. Dr. Gupta is affiliated with Atrium Medical Center, Christ Hospital, The Jewish Hospital and West Chester Hospital.
Dr. Gupta graduated from the Univ of Ibadan, Coll of Med, Ibadan, Oyo, Nigeria in 1986. He works in Indianapolis, IN and 2 other locations and specializes in Pediatric Gastroenterology. Dr. Gupta is affiliated with Deaconess Hospital, IU Health North Hospital and Riley Hospital For Children At Indiana University Health.
Dr. Gupta graduated from the Gov't Med Coll, Nagpur Univ, Nagpur, Maharashtra, India in 1989. He works in Minneapolis, MN and 1 other location and specializes in Nephrology. Dr. Gupta is affiliated with Allina Health Unity Hospital, North Memorial Medical Center and University Of Minnesota Medical Center East Bank.
Dr. Gupta graduated from the Maulana Azad Med Coll, Delhi Univ, New Delhi, Delhi, India in 1987. He works in Stony Brook, NY and 1 other location and specializes in Thoracic Surgery and Congenital Cardiac Surgery (Thoracic Surgery). Dr. Gupta is affiliated with Peconic Bay Medical Center, Southampton Hospital and Stony Brook University Hospital.
Dr. Gupta graduated from the Maulana Azad Med Coll, Delhi Univ, New Delhi, Delhi, India in 1987. He works in Houston, TX and 1 other location and specializes in Pulmonary Disease and Pulmonary Critical Care Medicine. Dr. Gupta is affiliated with Memorial Hermann Southeast Hospital.
Dr. Gupta graduated from the Sawai Man Singh Med Coll, Rajasthan Univ, Jaipur, Rajasthan, India in 1989. He works in Bronx, NY and 2 other locations and specializes in Rheumatology and Internal Medicine. Dr. Gupta is affiliated with Montefiore Medical Center, Saint Francis Hospital The Heart Center and South Nassau Communities Hospital.
Wikipedia References
Sandeep Gupta
Name / Title
Company / Classification
Phones & Addresses
Sandeep K. Gupta Medical Doctor
Reiley Hospital for Children, Pediactric Dept General Hospital · Medical Doctor's Office
Sandeep Gupta - Plainsboro NJ, US Gary Samoriski - Hillsborough NJ, US
Assignee:
Forest Laboratories, Inc. - New York NY
International Classification:
A61K031/551 A61K031/343
US Classification:
514220000, 514469000
Abstract:
The present invention provides a method for the treatment of depression, including treatment-resistant depression, and other mood disorders using a combination of an NMDA receptor antagonist and a SSRI that is citalopram or escitalopram. It has unexpectedly been shown that the combination has a synergistic and potentiated effect of either compound as monotherapy, resulting in an enhanced therapeutic effect at lower doses.
Use Of 1-Aminocyclohexane Derivatives To Modify Deposition Of Fibrillogenic A-Beta Peptides In Amyloidopathies
Sandeep Gupta - Plainsboro NJ, US Pradeep Banerjee - Hillsborough NJ, US Debomoy Lahiri - Indianapolis IN, US Martin Farlow - Indianapolis IN, US
Assignee:
Forest Laboratories, Inc. - New York NY
International Classification:
A61K031/13
US Classification:
514659000
Abstract:
The invention relates to the use of NMDA receptor antagonists such as 1-aminocyclohexane derivatives to modify deposition of potentially toxic and fibrillogenic Aβ peptides in amyloidopathies. Specifically, the invention relates to the ability of memantine to intervene in the processing of APP and decrease the levels of fibrillogenic Aβ peptides.
Memantine For The Treatment Of Childhood Behavioral Disorders
Jeffrey Jonas - Hoboken NJ, US Pradeep Banerjee - Hillsborough NJ, US Sandeep Gupta - Plainsboro NJ, US Allison Mann - Fort Lee NJ, US Hans-Joerg Moebius - Frankfurt, DE
International Classification:
A61K 31/13
US Classification:
514662000
Abstract:
The present invention provides a method for the treatment of individuals diagnosed with a childhood behavioral disorder such as autistic spectrum disorders or combined type Attention-Deficit/Hyperactivity Disorder (ADHD) by administering an effective amount of memantine.
Combination Of An Nmda Receptor Antagonist And A Selective Serotonin Reuptake Inhibitor For The Treatment Of Depression And Other Mood Disorders
Sandeep Gupta - Plainsboro NJ, US Gary Samoriski - Hisslborough NJ, US
Assignee:
MERZ PHARMA GmbH & CO. KGaA - Frankfurt am Main
International Classification:
A61K 31/13 A61K 31/343 A61P 25/24
US Classification:
514469, 514579
Abstract:
The present invention provides a method for the treatment of depression, including treatment-resistant depression, and other mood disorders using a combination of an NMDA receptor antagonist and a SSRI that is citalopram or escitalopram. It has unexpectedly been shown that the combination has a synergistic and potentiated effect of either compound as monotherapy, resulting in an enhanced therapeutic effect at lower doses.
Memantine For The Treatment Of Childhood Behavioral Disorders
Jeffrey Jonas - Hoboken NJ, US Pradeep K. Banerjee - Hillsborough NJ, US Sandeep Gupta - Plainsboro NJ, US Allison Mann - Fort Lee NJ, US Hans-Joerg Moebius - Frankfurt, DE
Assignee:
FOREST LABORATORIES HOLDINGS LIMITED - Hamilton
International Classification:
A61K 31/13 A61P 25/00
US Classification:
514662
Abstract:
The present invention provides a method for the treatment of individuals diagnosed with a childhood behavioral disorder such as autistic spectrum disorders or combined type Attention-Deficit/Hyperactivity Disorder (ADHD) by administering an effective amount of memantine.
Disclosed are methods of treating cancer, which include administering a therapeutically effective amount of a compound of Formula (I), or a pharmaceutically acceptable salt or ester thereof, to a subject in need thereof.Also disclosed are methods of inhibiting growth and proliferation of cancer cells in vitro or in vivo, which include contacting the cells with an amount of the compound of formula (I) effective to inhibit the growth or proliferation of the cancer cells. Further disclosed are methods of inhibiting tumor growth, which include contacting the tumor with an amount of the compound of formula (I) effective to inhibit the growth of the tumor.
Formulations, Methods, Kits, And Dosage Forms For Treating Atopic Dermatitis And For Improved Stability Of An Active Pharmaceutical Ingredient
- Lawrenceville NJ, US Paras Jariwala - Somerset NJ, US Wantanee Phuapradit - Montville NJ, US David Zammit - Fort Lee NJ, US Louis Denis - Princeton NJ, US Niranjan Rao - Montgomery NJ, US Helen Usansky - Hillsborough NJ, US Sandeep Gupta - Plainsboro NJ, US
International Classification:
A61K 31/519 A61K 9/20 A61P 17/00
Abstract:
Embodiments of the disclosure relate generally to formulations, methods of treatment, kits, and dosage forms for treating inflammatory disorders, including atopic dermatitis, or cancer, the formulations comprising an active pharmaceutical ingredient. The formulation provided comprises granules, wherein the granules comprise: micronized active ingredient; one or more granulation binders; one or more fillers; one or more disintegrants; and one or more antioxidants. In one embodiment, the methods of treatment include orally administering the active ingredient to a subject suffering from atopic dermatitis, where the active ingredient is in an amount of about 20 mg to about 80 mg.
Disclosed are methods of treating cancer, which include administering a therapeutically effective amount of a compound of Formula (I), or a pharmaceutically acceptable salt or ester thereof, to a subject in need thereof.Also disclosed are methods of inhibiting growth and proliferation of cancer cells in vitro or in vivo, which include contacting the cells with an amount of the compound of formula (I) effective to inhibit the growth or proliferation of the cancer cells. Further disclosed are methods of inhibiting tumor growth, which include contacting the tumor with an amount of the compound of formula (I) effective to inhibit the growth of the tumor.
Alexa on the Fire TV Cube cant do everything it can on a normal Echo speaker: in a briefing in New York City this week, Sandeep Gupta, Amazons vice president of smart TV and home products, specifically mentioned that it doesnt have any functionality in the way of communications. That means no tex
Walter Knott Elementary School Buena Park CA 1983-1985, W.R. Nelson Elementary School Tustin CA 1985-1989, Greentree Elementary School Irvine CA 1988-1989, Deerfield Elementary School Irvine CA 1989-1990, Venado Middle School Irvine CA 1990-1992